Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia

Fig. 3

Comparisons of the RUNX1-RUNX1T1 transcript levels at 1, 3, and 6 months among the patients in continuous CR, the patients who had experienced forthcoming relapse and the patients who had experienced late relapse. a RUNX1-RUNX1T1 transcript levels at 1-month post-HSCT. b RUNX1-RUNX1T1 transcript levels at 3 months post-HSCT. c RUNX1-RUNX1T1 transcript levels at 6 months post-HSCT

Back to article page